Working… Menu
Trial record 90 of 2594 for:    "Plasma Cell Neoplasm"

Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00005987
Recruitment Status : Terminated (Withdrawn because treatment guidelines changed)
First Posted : January 27, 2003
Last Update Posted : November 29, 2017
Information provided by (Responsible Party):
Masonic Cancer Center, University of Minnesota

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : July 2003
Actual Study Completion Date : July 2003